Rare diseases
Investigational molecules
Locations
140-14315 118 Avenue Northwest, T5L 4S6
Aurinia Pharmaceuticals Inc. is involved in clinical research focused on generalized myasthenia gravis, a chronic autoimmune neuromuscular disease that affects muscle strength and nerve-to-muscle communication.
The sponsor’s research interest in this area reflects attention to conditions requiring targeted immune modulation within neurology and autoimmune disease care.
Aurinia Pharmaceuticals Inc. runs clinical trials in conditions such as Myasthenia gravis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AUR200 for Patients with Generalized Myasthenia Gravis
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
